Multiple Switching Between the Biosimilar Adalimumab PF-06410293 (Abrilada (TM)) and Reference Adalimumab (Humira (R))in Combination with Methotrexate in Patients with Moderately to Severely Active Rheumatoid Arthritis
ARTHRITIS & RHEUMATOLOGY(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要